DUBLIN--(BUSINESS WIRE)--The "Global Adhesion Barriers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
The global adhesion barriers market was valued at US$ 536.5 Mn in 2017 and expected to reach US$ 980.2 Mn by 2026, expanding at a CAGR of 6.9% from 2018 to 2026.
Growing geriatric population, increasing the prevalence of chronic diseases and the need for surgical intervention in this group forms one of the key market drivers.
Among the various product types, the demand for synthetic adhesion barriers is observed to be the highest, therefore gathering the larger revenue share as against natural barriers. Better efficacy and cost-effectiveness of synthetic barriers form a key factor supporting the dominance of this segment.
Additionally, among the various surgical applications, adhesion barriers find the highest consumption in gynecological surgeries. High incidence of tissue and organ adhesion following hysterectomies and pelvic cancers is a key determinant of this trend.
Key Market Movements
- The increasing pool of the geriatric population, and a high risk of chronic diseases demanding surgical intervention
- The growing incidence of gynecological diseases and uterine cancers demanding hysterectomies and other forms of surgeries
- Increasing awareness about the benefits from adhesion barriers in preventing cost burden on treatments
- Growing market entry of players from the developed markets to the emerging regions and the Asia Pacific and Latin America
- Proliferating medical tourism in Latin America and the Asia Pacific urging the uptake of advanced surgical products and approaches
Topics Covered
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Adhesion Barriers Market Portraiture
2.2. Global Adhesion Barriers Market, by Product Type, 2017 (US$ Mn)
2.3. Global Adhesion Barriers Market, by Formulation, 2017 (US$ Mn)
2.4. Global Adhesion Barriers Market, by Surgical Application, 2017 (US$ Mn)
2.5. Global Adhesion Barriers Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Adhesion Barriers Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Adhesion Barriers Market, by Key Players, 2017
Chapter 4. Global Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Synthetic Barriers
4.2.1. Hyaluronic Acid
4.2.2. Polyethylene Glycol (PEG)
4.2.3. Regenerated Cellulose
4.2.4. Others
4.3. Natural Barriers
4.3.1. Fibrin
4.3.2. Collagen & Protein
Chapter 5. Global Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. Gel
5.3. Liquid
5.4. Film
Chapter 6. Global Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
6.1. Overview
6.2. Gynecology
6.3. Abdominal General Surgery
6.4. Cardiovascular
6.5. Neurology
6.6. Orthopedic
6.7. Urology
6.8. Others
Chapter 7. Global Adhesion Barriers Market, by Geography, 2016 - 2026 (US$ Mn)
7.1. Overview
7.2. North America Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
7.3. Europe Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
7.4. Asia Pacific Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
7.5. Latin America Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
7.6. Middle East & Africa Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
Chapter 8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Anika Therapeutics
8.3. C. R. Bard Inc.
8.4. FzioMed
8.5. Baxter International
8.6. Sanofi-Aventis U.S. LLC
8.7. W. L. Gore & Associates
8.8. MAST Biosurgery Inc.
8.9. Integra LifeSciences Holdings Corporation
8.10. Becton Dickinson and Company
8.11. Atrium Medical Corporation
For more information about this report visit https://www.researchandmarkets.com/r/it4lcl
